SIGA Technologies
SIGA
#8832
Rank
โ‚น22.75 B
Marketcap
โ‚น316.71
Share price
-5.60%
Change (1 day)
-56.63%
Change (1 year)

SIGA Technologies (SIGA) - Total debt

Total debt on the balance sheet as of June 2026 : โ‚น42.36 Million

According to SIGA Technologies's latest financial reports the company's total debt is โ‚น42.36 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

SIGA Technologies - Total debt on balance sheet (from 1998 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚น53.42 M13.9%
2024-12-31โ‚น46.9 M-0.09%
2023-12-31โ‚น46.95 M7.43%
2022-12-31โ‚น43.7 M25.78%
2021-12-31โ‚น34.74 M5.59%
2020-12-31โ‚น32.9 M-99.43%
2019-12-31โ‚น5.73 B8.62%
2018-12-31โ‚น5.28 B16.44%
2017-12-31โ‚น4.53 B0.31%
2016-12-31โ‚น4.52 B
2014-12-31โ‚น0.12 B-48.43%
2013-12-31โ‚น0.24 B-9.03%
2012-12-31โ‚น0.26 B
2006-12-31โ‚น5.77 M-40.12%
2005-12-31โ‚น9.64 M
2002-12-31โ‚น0.53 M-94.21%
2001-12-31โ‚น9.27 M-83.98%
2000-12-31โ‚น57.87 M66.3%
1999-12-31โ‚น34.8 M-25.59%
1998-12-31โ‚น46.77 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น100.83 B 237,919.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น28.66 B 67,565.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น0.47 B 1,016.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.14 B 241.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น76.43 B 180,337.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น56.09 B 132,308.73%๐Ÿ‡บ๐Ÿ‡ธ USA